SPM 929

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

SeizureDiabetic NeuropathyPostherpetic NeuralgiaRestless Legs SyndromeSleep Disorder

109 competitors in Seizure

#DrugCompanyPhaseTrials

1

Briviact

UCB

Phase 3

122

Afinitor

Novartis

Phase 3

13

Fintepla

IImmedica Pharma AB

Phase 3

34

E2007

Eisai

Phase 3

65

Prozac

VVitae Pharmaceuticals Inc., an Allergan affiliate

Phase 3

16

Ativan

BBausch Health Americas, Inc.

Phase 3

17

Epsom Salt

FFresenius Kabi Oncology Ltd.

Phase 3

18

Valproate Sodium

Sanofi

Phase 3

19

RWJ-333369

SSK Life Science, Inc.

Phase 3

410

Carisbamate

SSK Life Science, Inc.

Phase 3

4Show 34 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Parkinson's Disease7 trials

A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients

Completed·Otsuka·Phase 2·NCT01634243·64 enrolled

A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

Completed·Otsuka·Phase 3·NCT01628926·420 enrolled

A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

Completed·Otsuka·Phase 2·NCT01628848·174 enrolled

Show 4 more trials

A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

Completed·Otsuka·Phase 2/3·NCT01628965·143 enrolled

A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

Completed·Otsuka·Phase 3·NCT01631825·321 enrolled

A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

Completed·Otsuka·Phase 2/3·NCT00537485·180 enrolled

A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients

Completed·Otsuka·Phase 2·NCT01631812·130 enrolled

Restless Legs Syndrome4 trials

A Long-Term Extension Trial From Late Phase II of SPM 962 in Patients With Restless Legs Syndrome

Completed·Otsuka·Phase 2·NCT01562743·185 enrolled

Rotigotine Restless Legs Syndrome Dose Finding Trial

Completed·UCB·Phase 2·NCT00243217·341 enrolled

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

Completed·Otsuka·Phase 3·NCT01084551·284 enrolled

Show 1 more trial

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

Completed·Otsuka·Phase 2·NCT00666965·230 enrolled

Diabetic Neuropathy4 trials

A Trial to Assess the Efficacy and Safety of SPM 927 in Subjects With Painful Distal Diabetic Neuropathy

Completed·UCB·Phase 2/3·NCT00235469·496 enrolled

A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy

Completed·UCB·Phase 3·NCT00350103·551 enrolled

A Trial to Assess the Efficacy and Safety of SPM 927 (Lacosamide) in Subjects With Painful Distal Diabetic Neuropathy

Completed·UCB·Phase 3·NCT00238524·357 enrolled

Show 1 more trial

Trial to Assess the Efficacy and Safety of SPM 927 (200, 400, and 600mg/Day) in Subjects With Painful Distal Diabetic Neuropathy

Completed·UCB·Phase 3·NCT00135109·654 enrolled

Seizure3 trials

Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial Seizures

Completed·UCB·Phase 2/3·NCT00151879·160 enrolled

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Completed·UCB·Phase 3·NCT00220415

SPM 927 (400mg/Day and 600mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Completed·UCB·Phase 3·NCT00136019·400 enrolled

Sleep Disorder1 trial

A Trial to Compare the Efficacy of Rotigotine Transdermal Patch to That of Ropinirole on Early Morning Motor Impairment and Sleep Disorders in Subjects With Early-Stage, Idiopathic Parkinson's Disease

Completed·UCB·Phase 3·NCT00243971

2 more indications

Postherpetic Neuralgia1 trial

An Open-Label Follow-on Trial to Assess the Long-Term Safety and Efficacy of Oral SPM 927 in Subjects With Postherpetic Neuralgia (PHN)

Completed·UCB·Phase 2·NCT00238511

Idiopathic Parkinson's Disease1 trial

Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

Completed·UCB·Phase 3·NCT00244387·506 enrolled

Details

Drug Info

Related News